TransMedics Group Stock Gets Positive Review from Piper Sandler for its Valuation

Thursday, 28 March 2024, 16:32

TransMedics Group (TMDX) stock has surged following Piper Sandler's initiation of coverage with an Overweight rating and a price target of $95. The report highlights the company's attractive valuation, driving investor interest and optimism in the stock. Piper Sandler's bullish view on TransMedics showcases the potential for significant upside in the stock price based on current valuation metrics.

https://store.livarava.com/a1e0cebf-ed21-11ee-8904-87cc5c87fb08.jpg — TransMedics Group Stock Gets Positive Review from Piper Sandler for its Valuation

TransMedics Group Stock Receives Positive Review

TransMedics Group (TMDX) stock gains as Piper Sandler initiated coverage with an Overweight rating and $95 price target, citing attractive valuation.

This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.

TransMedics Group Stock Receives Positive Review

Related posts